{
  "ticker": "MYX",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02977690",
  "id": "02977690",
  "pages": 7,
  "price_sensitive": false,
  "date": "20250806",
  "time": "1817",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250806/pdf/06mly5kzl52jy6.pdf",
  "summary": "- **Substantial Holder Update**: The Goldman Sachs Group increased its stake in Mayne Pharma Group Limited.  \n- **Previous Holding**: 7.21% (5,854,959 shares).  \n- **Current Holding**: 8.30% (6,743,487 shares).  \n- **Net Increase**: +888,528 shares (1.09% voting power).  \n\n*No other material information identified.*",
  "usage": {
    "prompt_tokens": 4394,
    "completion_tokens": 88,
    "total_tokens": 4482,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-08-06T08:57:05.076997"
}